Dilatrend

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dilatrend

Property Description
Active ingredient Carvedilol
Form Oral tablet or capsule
Pharmacological class Adrenergic Alpha- and Beta-Antagonist (Dual alpha- and beta-receptor blocker)
Origin Synthetic (chemically synthesized)
General Purpose Reduces strain on the heart, promotes vasodilation, and manages cardiovascular health

What Type of Medicine is Dilatrend (Carvedilol)?

Dilatrend is the brand name for the prescription-only medication whose active ingredient is Carvedilol (INN), a synthetic, single-ingredient cardiovascular agent. This drug is classified as an alpha-/beta-adrenergic blocking agent. Carvedilol is distinguished by its unique action as a dual alpha- and beta-receptor blocker, a feature that sets it apart from conventional beta-blockers. This dual mechanism is the primary differentiating factor, restricting the activity of stress hormones, such as adrenaline and noradrenaline, across both beta-receptors and alpha-1 receptors.

Composition, Forms, and General Therapeutic Benefit

The active substance, Carvedilol, is provided for administration via the oral route in the form of a conventional tablet or an extended-release capsule. The compound is a highly lipophilic racemic mixture of R(+) and S(–) enantiomers, both of which are active in delivering the alpha-blocking properties. Its general purpose is the efficient management of the circulatory system. This is achieved by reducing the overall workload placed on the heart through slowing the heart rate while concurrently promoting systemic vasodilation (widening of blood vessels). This mechanism helps manage conditions characterized by high vascular resistance and increased strain on the heart muscle.

What side effects are possible with Dilatrend?

Dilatrend's (Carvedilol) safety profile is defined by government regulatory agencies through classifications of adverse reactions by frequency and physiological system. This official documentation details the scope of known effects, safety constraints, and specific considerations for certain patient populations.

Official Adverse Reactions and Frequency

Adverse reactions are officially categorized by their frequency. Very Common (ge 1/10) documented effects include dizziness, headache, fatigue (asthenia), and hypotension (low blood pressure). Common effects (ge 1/100 to < 1/10) include bradycardia (slow heart rate), postural hypotension, and peripheral oedema (swelling), alongside gastrointestinal effects such as nausea, vomiting, and diarrhea.

Adverse effects span major physiological systems, including Cardiac disorders, Vascular disorders, Nervous system disorders, and Metabolism and nutrition disorders. Uncommon effects include syncope (fainting), atrioventricular block, and depression.

Serious Safety Considerations

The regulatory label documents Serious Adverse Reactions, including the very rare risk of Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Exacerbation of heart failure or fluid retention is noted as a specific concern, particularly during the period of dose adjustment.

Population-Specific Safety Notes

The medicine is officially contraindicated (should not be used) in individuals with severe hepatic impairment and in those with certain severe pre-existing cardiac conduction disorders (e.g., second- or third-degree AV block). For patients with diabetes mellitus, the drug may mask the symptoms of acute hypoglycemia. Furthermore, official safety patterns note that effects like dizziness and hypotension are more prominent during the initial phase of therapy or following dose increases.

Overdose and Emergency Response

Overdose and when to seek help

This information reflects only the officially documented overdose profile for Dilatrend (Carvedilol), as stated in government regulatory documents.

Category Regulatory Statement
Documented overdose presentations: Severe bradycardia (slow heart rate) and profound hypotension (low blood pressure), respiratory distress (bronchospasm), generalized seizures, vomiting, and disturbed consciousness.
Physiological systems affected: Cardiovascular system, Central Nervous System, and Respiratory system.
Dose-related factors: Official labeling focuses on resulting clinical manifestations rather than specifying the single toxic dose quantity.
Population-specific notes: No specific population-based considerations are defined in the regulatory overdose sections.
Emergency-response statements: Seek immediate medical attention for any suspected overdose. Contact the Poison Control Helpline for specific guidance.
When immediate help is required (label phrasing): Call emergency services immediately if the individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.

Overdose classifications (high-level)

Category Regulatory Statement
Severity classification: Overdose is classified as capable of producing life-threatening outcomes including cardiac arrest and cardiogenic shock.
Overdose-context constraints: Management requires intensive care monitoring and symptomatic and supportive treatment.

Resulting overdose structure

Official overdose statements:

  • Life-threatening consequences officially documented include cardiogenic shock, cardiac arrest, and acute heart failure.
  • Specific management procedures include the use of Atropine for severe bradycardia.
  • Carvedilol is not removable by hemodialysis.

Connection to the overall overdose profile: Regulatory documents define the Carvedilol overdose profile based on severe, rapid-onset cardiovascular and respiratory compromise. The official instructions mandate immediate contact with emergency services when the most severe symptoms, such as collapse or seizure, are present, emphasizing the need for intensive care and symptomatic and supportive measures.

Therapeutic Uses of Dilatrend

What Dilatrend Treats: Main Uses and Benefits

Dilatrend (Carvedilol) is generally applied in contexts involving cardiovascular disease states, providing crucial supportive care. The medication plays a role in managing conditions marked by systemic discomfort and symptoms that interfere with daily functioning.

The main therapeutic uses generally include: Long-Term Management of Chronic Heart Failure, Control of Essential Hypertension, and Supporting Heart Function After Myocardial Infarction in clinically stable patients.

In these settings, the medication is applied across domains where additional symptomatic support is needed. Its use helps patients with Chronic Heart Failure by easing the overall burden of symptoms like undue fatigue and shortness of breath (dyspnea). For those with high blood pressure, it contributes to easing the overall symptom load and may assist with maintaining functional stability.

“The primary goal of its use is to help maintain a sense of stability when symptoms are more noticeable, supporting the patient during difficult episodes by easing distress.”


Quick Fact: Relief for Circulatory Strain The medication supports patients by addressing symptoms related to systemic imbalance, which can manifest as fatigue and functional limitation.


Eligibility and Restrictions for Use

Population Eligibility for Dilatrend (Carvedilol)

Eligibility for Dilatrend is defined by regulatory agencies based on a patient's pre-existing conditions and age. The medicine is primarily approved for use in the adult population to manage essential hypertension, chronic heart failure, and left ventricular dysfunction after a heart attack.

Classification Eligibility Status as Stated in Official Labeling
Absolute Contraindication Patients must not use Dilatrend if they have severe hepatic impairment, bronchial asthma or related bronchospastic conditions, severe bradycardia (slow heart rate), cardiogenic shock, or second- or third-degree AV block (unless a permanent pacemaker is present).
Restricted/Conditional Use Use requires caution and close monitoring in patients with diabetes mellitus, non-allergic bronchospasm (e.g., chronic bronchitis), or peripheral vascular disease, as the drug may affect these conditions.
Age Restriction Safety and effectiveness have not been established in children and adolescents under 18 years of age. No specific restrictions limit use in older adults.
Pregnancy/Lactation Use is not recommended during pregnancy unless the benefit clearly outweighs the potential risk. It is also not recommended during breastfeeding as the medicine is excreted into human milk.

These official rules strictly define the eligible and non-eligible groups for Dilatrend according to regulatory standards.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Dilatrend (carvedilol) may interact with various medicines by influencing its blood concentration or by having additive effects on the heart rate and blood pressure. Combining certain products requires close monitoring by a healthcare professional.

Clinically Significant Combinations

Interacting Product Category Potential Effect and Clinical Action
Heart Rate Slowing Agents (e.g., Amiodarone, Digoxin, Verapamil, Diltiazem) Additive effects may cause severe bradycardia (very slow heart rate) or heart block. ECG and blood pressure monitoring is essential. Carvedilol may also increase Digoxin levels.
Blood Pressure Lowering Agents (e.g., Hypotensive drugs, Clonidine) Additive effects may result in excessive hypotension and/or severe bradycardia. Patients must be closely monitored. For Clonidine discontinuation, Dilatrend must be stopped first.
CYP2D6 Inhibitors (e.g., Fluoxetine, Paroxetine) These may increase Dilatrend blood levels, raising the risk of enhanced effects like low blood pressure and slow heart rate.
Cyclosporine Dilatrend may significantly increase Cyclosporine blood levels, requiring monitoring and potential dosage reduction of Cyclosporine.
Rifampin This enzyme inducer may significantly decrease Dilatrend blood levels, potentially reducing its effectiveness.
Antidiabetic Agents (e.g., Insulin, Metformin) Dilatrend may enhance the blood glucose-lowering effect of these medicines and may mask or prolong the signs of low blood sugar.

Mechanism of Action

Adrenergic Receptor Blockade and Vascular Tone Modulation

The primary mechanism of action involves the dual antagonism of both beta-adrenergic receptors (beta1 and beta2) and alpha1-adrenergic receptors. This antagonism suppresses the agonistic effects of circulating catecholamines (stress hormones) on target receptors. The beta1 blockade decreases the heart's intrinsic pace and contractility and the alpha1 blockade inhibits vasoconstriction. This modulation of autonomic pathways induces a reduction in myocardial workload and Systemic Vascular Resistance (SVR).


Non-Adrenergic Mechanisms and Antioxidant Activity

In addition to receptor blockade, the drug engages a distinct non-adrenergic mechanism by acting as an intrinsic antioxidant. This function involves the inhibition of oxygen free radical generation, thereby modulating cellular pathways sensitive to oxidative stress. This mechanism is engaged in pathways driven by chronic neurohormonal activity, resulting in alterations to the overall physiological response.

Dosage and Administration Information

How to Use Dilatrend: Official Administration Guidelines

Dilatrend (Carvedilol) is administered exclusively via the oral route as either an immediate-release (IR) tablet or an extended-release (ER) capsule. A critical instruction for proper use is that the medication must be taken with food to modulate its absorption and reduce the likelihood of certain effects.

Dosing Schedule and Titration:

Treatment typically begins with a low initial dose that is gradually increased over several weeks under a process called titration. For example, immediate-release tablets for Chronic Heart Failure start at 3.125 mg twice daily. The dose is maintained for intervals of at least two weeks before any increase is considered. This slow, step-wise approach is essential for proper administration.

Dosage Form Frequency Pattern
Immediate-Release Tablet Twice Daily
Extended-Release Capsule Once Daily (typically in the morning)

Special Administration Conditions:

Extended-release capsules must be swallowed whole and may not be crushed or chewed; however, they may be opened and the contents sprinkled onto a small amount of applesauce and consumed immediately. Discontinuation of therapy must also follow a procedural pattern; the drug should not be stopped abruptly but rather gradually reduced over a period of one to two weeks. No dosage adjustment is generally necessary for patients with renal impairment, but use is contraindicated in severe hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dilatrend (Carvedilol)


Research Evidence for Chronic Heart Failure

The research base for Dilatrend in managing Chronic Heart Failure (CHF) was evaluated through large-scale, international Randomized Controlled Trials (RCTs). These trials were conducted primarily on adult patients with heart failure of varying severity, generally while they were already receiving other standard therapies. Researchers focused on monitoring long-term outcomes related to physiological strain and functional imbalance, including all-cause mortality and the frequency of hospitalization.

Major studies monitored patterns related to all-cause mortality, describing the frequency of reported events in the study group compared to the control group. Findings also indicated patterns related to the frequency of reported hospitalization for cardiovascular reasons. Research also described measurements of the heart's pumping function (LVEF), reporting changes in the observed populations over the observation period.


Research Evidence for Supporting Heart Function After Myocardial Infarction

Dilatrend was evaluated in major clinical trials focused on patients who had recently survived a heart attack (Myocardial Infarction or MI) and who were found to have reduced Left Ventricular (LV) function. These studies observed adult patients over intermediate-term follow-up periods, examining all-cause mortality, the recurrence of a non-fatal MI, and how the heart muscle restructured itself.

Data showed patterns related to all-cause and cardiovascular mortality, with research describing the frequency of reported events in the study group. Research also described patterns related to the frequency of non-fatal MI events. Studies monitored changes in LV remodeling measures in the treated populations.


Evidence Gaps and Areas of Research Uncertainty

While studies contribute to the broader evidence landscape, data for certain patient groups remain insufficient or uncertain. For example, findings from trials involving children and adolescents with chronic heart failure were mixed, indicating that the data for this specific group remain insufficient to draw the same conclusions seen in adults. Additionally, for managing hypertension, comparative evidence is lacking regarding how long-term outcomes compare when using Dilatrend versus all other antihypertensive medications.

Key Studies & References

  1. Controlled-Release Carvedilol in the Treatment of Essential Hypertension

Frequently Asked Questions (FAQ)

Common questions about Dilatrend (FAQ)


Q: Does Dilatrend cause weight gain?

Studies have examined the effects of Dilatrend in clinical trials for heart conditions. Official documentation notes that weight increase has been reported as an adverse event in patients treated for heart failure and left ventricular dysfunction following a heart attack (myocardial infarction).

Q: Can Dilatrend affect sleep or cause insomnia?

According to official safety information, difficulty sleeping, or insomnia, is listed as an uncommon adverse reaction. This means it is reported in less than 1 in 100 people in clinical trials.

Q: How long does it take for Dilatrend to start working or for me to feel a difference?

The initial effects on heart rate and blood pressure often begin within one hour of taking the medication. However, official information indicates that the full desired therapeutic effect may take several weeks, as the dosage is slowly and gradually adjusted.

Q: What happens if I forget to take my Dilatrend dose?

Official administration guidelines describe taking the missed dose as soon as it is remembered. However, regulatory guidelines describe skipping the missed dose and continuing with the next scheduled dose if the time gap is too short (e.g., less than 5 or 6 hours for twice-daily medication). Official guidance advises against taking two doses simultaneously.

Q: Can Dilatrend be taken with common pain relievers like ibuprofen or aspirin?

Official drug interaction data indicates that combining Dilatrend with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen or aspirin, may reduce the intended blood pressure-lowering effect of Dilatrend. Regulatory compliance requires a healthcare professional to review all medications before they are taken together.

Q: Does Dilatrend interact with supplements like fish oil or magnesium?

While many common supplements are not listed as clinically significant interactions, some regulatory sources advise that multivitamins containing minerals may decrease the effects of carvedilol. If taking these, a time separation between the supplement and the medication may be necessary.

Q: Can Dilatrend affect driving ability?

Due to the risk of common side effects like dizziness, tiredness, and feeling lightheaded, official documents advise caution. These effects can potentially impair the ability to drive, operate machinery, or perform other hazardous tasks, particularly when starting treatment, after a dose increase, or when used with alcohol.

Q: Is it possible to be allergic to Dilatrend?

Yes, the medicine is officially contraindicated (should not be used) in people with a history of a serious hypersensitivity or allergic reaction to any component of the medication. This includes rare but severe reactions like Stevens-Johnson syndrome.

Q: Does Dilatrend interact with cold and flu medicines?

Many cold and flu medicines contain ingredients, such as decongestants, that can increase heart rate or blood pressure. Official warnings regarding interactions advise caution when combining Dilatrend with other agents that lower blood pressure, as the effects can be additive.

Q: Why is Dilatrend sometimes prescribed along with diuretics (water pills)?

Official guidance is available regarding the management of worsening heart failure symptoms during the period of dose adjustment. Official documentation notes that if a patient experiences fluid retention during dose adjustment, the regulatory protocol suggests managing the fluid retention by adjusting the diuretic dose before changing the Dilatrend dose.

Q: Does taking Dilatrend affect routine blood test results?

Adverse event reports noted in official documentation include rare instances of changes in certain blood tests. These include elevated liver enzymes and changes in blood sugar (hyperglycemia), which may be reflected in routine blood work, particularly in patients who have diabetes.

Q: Are there any official studies looking at Dilatrend for conditions other than heart disease?

Yes, Dilatrend is approved for multiple uses beyond heart failure and left ventricular dysfunction after a heart attack. The medication is also officially indicated for the management of essential hypertension, which is the medical term for high blood pressure.

Q: What are the signs of taking too much Dilatrend (overdose symptoms)?

Official regulatory information indicates that signs of an overdose may include severe low blood pressure (hypotension), a very slow heart rate (bradycardia), difficulty breathing, and vomiting. In severe cases, the signs can progress to shock or seizures.

Q: Does Dilatrend cause sexual side effects?

Official adverse reaction documentation lists impotence or erectile dysfunction as an uncommon side effect. This means it has been reported in less than 1 in 100 people in clinical trials.

Q: Does Dilatrend interact with alcohol?

Yes, official warnings state that alcohol can have additive effects with Dilatrend in lowering blood pressure. This combination may increase the risk of symptoms such as dizziness, lightheadedness, or fainting.

Q: Are there any specific foods or drinks I should avoid while taking Dilatrend?

Official warnings state that the medication must be taken with food to properly control its absorption and reduce certain effects. Regulatory documents also advise that alcohol should be avoided as it can increase the risk of low blood pressure and dizziness.

Q: Is Dilatrend safe to use for people with diabetes?

Official safety warnings indicate that caution and close monitoring are necessary for individuals with diabetes. Dilatrend may mask or prolong the typical symptoms of low blood sugar (hypoglycemia) and may enhance the effects of other antidiabetic agents.

Q: What is the connection between Dilatrend and heart rhythm problems?

The medication is known to slow the heart rate, a common effect called bradycardia. Because of this, official documents state the medicine is contraindicated (should not be used) in patients with severe bradycardia or certain pre-existing heart conduction disorders.

Q: How often are the reported side effects serious?

Official documentation lists the most common side effects (dizziness, fatigue, low blood pressure) as very common, meaning they are experienced by 1 in 10 people or more. However, serious adverse reactions, such as severe skin conditions like Stevens-Johnson syndrome (SJS), are noted as a very rare risk.

Q: What is the typical dosage strength of Dilatrend?

The immediate-release tablets are available in several strengths, including 3.125 mg, 6.25 mg, 12.5 mg, and 25 mg. Official labeling indicates that the maximum recommended target dose for heart failure for specific patient groups is 25 mg taken twice daily. The determination of the correct strength is based on individual patient needs.

Q: What is the long-term safety profile of Dilatrend?

Studies have monitored long-term outcomes in patients with chronic heart failure and post-MI left ventricular dysfunction. This evidence examined factors such as all-cause mortality and hospitalization frequency. The medication is intended for long-term management of these chronic cardiovascular conditions.

Q: Are there different brand names for the same medicine as Dilatrend?

Dilatrend contains the active ingredient carvedilol. In the United States, another common brand name for this medication is Coreg. The medicine is also widely available under its generic name, carvedilol.

Q: Why do official documents warn against abrupt discontinuation of Dilatrend?

Official regulatory warnings advise against stopping the medication suddenly because it can lead to a severe worsening of angina (chest pain). Furthermore, abrupt cessation carries a risk of heart attack (myocardial infarction) and dangerous ventricular arrhythmias, especially for those with coronary artery disease.

Q: What does the term 'non-selective beta-blocker' mean in relation to Dilatrend?

Official documents classify Dilatrend as an alpha- and beta-adrenergic blocking agent. This means that in addition to blocking the alpha1 receptors, it blocks both types of beta-receptors (beta1 and beta2), which is the characteristic of non-selective beta blockade.

Q: How does Dilatrend affect the kidneys or liver?

Official guidelines state that the drug is contraindicated (should not be used) in patients with severe hepatic (liver) impairment. While dosage adjustment is not usually necessary for mild renal (kidney) impairment, rare instances of worsening kidney function have been reported in heart failure patients.

Q: Do I need to check my pulse or blood pressure regularly while taking Dilatrend?

Regulatory guidance includes information that patients who experience signs such as dizziness or lightheadedness should seek consultation, as these may indicate low blood pressure. Regulatory sources also mandate close monitoring of blood pressure and heart rate when Dilatrend is combined with certain other heart medications.

How should Dilatrend be stored and disposed of?

How to Store and Dispose of Dilatrend? (Official Regulatory Information)

Storage & Disposal Scope Official Requirements
Storage Temperature Store at 20^circ to 25 C (68^circ to 77 F), corresponding to Controlled Room Temperature.
Protection Requirements Protect the medicine from both moisture and light.
Packaging Rules Tablets must be dispensed in a tight, light-resistant container.
Child Safety Keep out of the reach of children.
Stability Note If extended-release capsule contents are mixed with applesauce, the mixture must be consumed immediately and not stored.
Disposal Instructions Safely dispose of medicine that is out of date or no longer needed, and consult a healthcare professional for guidance on disposal.

Official labeling defines strict environmental control, mandating that the product be kept within a specific room temperature range and protected from moisture and light to ensure stability. This protective requirement is supported by the rule that the product must be dispensed in a light-resistant container. Furthermore, official documents require child-access restrictions and instruct users to safely discard unused medicine after seeking professional advice.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dilatrend found in:

A-Z Index: